UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 295

Sortiert nach

Novel TCR-based biologics: mobilising T cells to warm ‘cold’ tumours

Cancer treatment reviews, 2019-07, Vol.77, p.35-43

2019

Link zum Volltext

Verfügbarkeit prüfen

ImmTACs for targeted cancer therapy: Why, what, how, and which

Molecular immunology, 2015-10, Vol.67 (2), p.67-74

2015

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine and neurotoxicity in engineered T-cell therapy

Gene therapy, 2018-06, Vol.25 (3), p.176-191

2018

Link zum Volltext

Verfügbarkeit prüfen

Different affinity windows for virus and cancer‐specific T‐cell receptors: Implications for therapeutic strategies

European journal of immunology, 2012-12, Vol.42 (12), p.3174-3179

2012

Link zum Volltext

Verfügbarkeit prüfen

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells

Immunology, 2017-11, Vol.152 (3), p.425-438

2017

Link zum Volltext

Verfügbarkeit prüfen

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

PLoS pathogens, 2023-12, Vol.19 (12), p.e1011853-e1011853

2023

Link zum Volltext

Verfügbarkeit prüfen

ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells

Cancer Immunology, Immunotherapy, 2014-05, Vol.63 (5), p.437-448

2014

Link zum Volltext

Verfügbarkeit prüfen

Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA

The Journal of clinical investigation, 2020-05, Vol.130 (5), p.2673-2688

2020

Link zum Volltext

Verfügbarkeit prüfen

Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor

The Journal of biological chemistry, 2009-10, Vol.284 (40), p.27281-27289

2009

Link zum Volltext

Verfügbarkeit prüfen

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy

Scientific reports, 2016-01, Vol.6 (1), p.18851, Article 18851

2016

Link zum Volltext

Verfügbarkeit prüfen

Human TCR-Binding Affinity is Governed by MHC Class Restriction

Journal of Immunology, 2007-05, Vol.178 (9), p.5727-5734

2007

Link zum Volltext

Verfügbarkeit prüfen

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex

The Journal of immunology (1950), 2020-04, Vol.204 (7), p.1943-1953

2020

Link zum Volltext

Verfügbarkeit prüfen

The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity

PloS one, 2013-10, Vol.8 (10), p.e79082

2013

Link zum Volltext

Verfügbarkeit prüfen

Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor

Molecular therapy, 2015-09, Vol.23 (9), p.1541-1550

2015

Link zum Volltext

Verfügbarkeit prüfen

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

The Journal of immunology (1950), 2008-05, Vol.180 (9), p.6116-6131

2008

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes

Nature immunology, 2012-03, Vol.13 (3), p.283

2012

Link zum Volltext

Verfügbarkeit prüfen

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

Blood, 2011-07, Vol.118 (2), p.319-329

2011

Link zum Volltext

Verfügbarkeit prüfen

TCR‐induced alteration of primary MHC peptide anchor residue

European journal of immunology, 2019-07, Vol.49 (7), p.1052-1066

2019

Link zum Volltext

Verfügbarkeit prüfen

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

Molecular therapy, 2016-11, Vol.24 (11), p.1913-1925

2016

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005782-e1005782

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(149)
Life Sciences & Biomedicine
(139)
Humans
(118)
Female
(37)
Immunology
(33)
Biological And Medical Sciences
(32)
Biochemistry & Molecular Biology
(29)
Receptors, Antigen, T-Cell - Immunology
(29)
Middle Aged
(27)
Amino Acid Sequence
(24)
Medical Sciences
(24)
Adult
(23)
Oncology
(23)
Cancer
(20)
Aged
(19)
Receptors, Antigen, T-Cell - Genetics
(19)
Animals
(18)
Male
(18)
Receptors, Antigen, T-Cell - Chemistry
(18)
Surface Plasmon Resonance
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel TCR-based biologics: mobilising T cells to warm ‘cold’ tumours

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules

ImmTACs for targeted cancer therapy: Why, what, how, and which

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Fludarabine and neurotoxicity in engineered T-cell therapy

Different affinity windows for virus and cancer‐specific T‐cell receptors: Implications for therapeutic strategies

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells

Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA

Monoclonal TCR-redirected tumor cell killing

Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy

Human TCR-Binding Affinity is Governed by MHC Class Restriction

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex

The tumor targeted superantigen ABR-217620 selectively engages TRBV7-9 and exploits TCR-pMHC affinity mimicry in mediating T cell cytotoxicity

Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor

Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions

Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

TCR‐induced alteration of primary MHC peptide anchor residue

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function

Suchergebnisse filtern